Pipette Calibration Services Market

The report "Pipette Calibration Services Market by Sevice Type (On-site, Off-site, Hybrid), Service Provider Type (OEM, Independent, Distribution led), Intrument (Single, Multi Channel, Electronic), End User (Pharma & Biotech, CROs/CDMO) - Global Forecast to 2031" is projected to reach USD 834.8 million by 2031 from USD 383.2 million in 2026, at a CAGR of 16.9%.

Browse 350 market data Tables and 50 Figures spread through 450 Pages and in-depth TOC on "Pipette Calibration Services Market, By Sevice Type (On-site, Off-site, Hybrid), Service Provider Type (OEM, Independent, Distribution led), Intrument (Single, Multi Channel, Electronic), End User (Pharma & Biotech, CROs/CDMO) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pipette-calibration-services-market-144210658.html

The increasing complexity of laboratory workflows and the expanding footprint of pharmaceutical, biotech, and clinical testing operations are driving demand for professional pipette calibration services as labs move toward standardized, traceable measurement practices. According to Mettler Toledo, up to 35% of pipettes sent for calibration are found out-of-specification, underscoring the scale of volumetric risk across active lab fleets. Additionally, ILAC reports that over 114,600 laboratories across 122 economies are accredited under its Mutual Recognition Arrangement as of 2025, reflecting the growing base of ISO/IEC 17025-accredited facilities that require traceable equipment calibration. Rising adoption of electronic and multichannel pipettes, automated liquid handling, and connected equipment-tracking software is pushing providers toward more standardized documentation and as-found/as-left reporting. The 2022 revision of ISO 8655, which introduced stricter tolerances and balance requirements, is further prompting labs to upgrade calibration protocols. Despite this momentum, growth is challenged by inconsistent calibration intervals, a shortage of accredited technicians, budget constraints at smaller labs, and uneven standardization across multi-site networks. Nevertheless, rising investment in on-site and mobile calibration, digital record-keeping, and preventive maintenance is expected to sustain steady growth in the pipette calibration services market.

By instrument, the electronic/motorized segment is projected to grow at the highest CAGR during the forecast period”

In terms of instrument, the electronic/motorized segment is expected to witness the fastest growth in the pipette calibration services market during the forecast period. This growth is driven by the increasing adoption of electronic pipettes in pharmaceutical, biotechnology, clinical, and research laboratories to improve dispensing consistency, minimize operator-dependent variability, and support high-throughput workflows. Electronic pipettes offer programmable volume settings, automated dispensing modes, and enhanced ergonomics, making them increasingly suitable for repetitive and precision-intensive applications. Their growing use in automated and semi-automated laboratory workflows is also increasing the need for specialized calibration and performance verification. Furthermore, electronic pipettes incorporate more sophisticated electronic and mechanical components, creating greater requirements for periodic accuracy checks, preventive maintenance, battery and component servicing, and manufacturer- or service-provider-specific diagnostics. The expansion of genomics, molecular diagnostics, cell-based research, and high-throughput screening is expected to further increase the utilization of electronic liquid-handling instruments. Consequently, the growing shift from manually operated pipettes toward programmable, automated, and digitally enabled liquid-handling systems is expected to drive demand for calibration and maintenance services for electronic/motorized pipettes throughout the forecast period.

In 2025, the OEM/manufacturer-affiliated segment accounted for the largest share of the pipette calibration services market

By service provider type, the OEM/manufacturer-affiliated segment accounted for the largest share of the pipette calibration services market in 2025. This dominance is primarily attributed to the strong preference of laboratories for manufacturer-supported calibration and maintenance services that provide instrument-specific expertise, standardized procedures, and access to original components and technical documentation. Pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and academic research institutions often rely on OEM service networks to maintain the performance and accuracy of their pipettes, particularly for specialized electronic, multichannel, and high-precision instruments. In addition, OEM-affiliated providers can offer integrated services covering calibration, preventive maintenance, repair, certification, and replacement of critical components, simplifying equipment lifecycle management for laboratories. The increasing adoption of sophisticated pipetting technologies and growing emphasis on equipment traceability, quality assurance, and compliance are further supporting demand for manufacturer-backed services. Moreover, established global service networks and trained technicians enable OEMs to provide standardized calibration support across multiple laboratory locations, strengthening the segment's market position in 2025.

Asia Pacific to be the fastest growing market during the forecast period.

The pipette calibration services market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is expected to be the fastest-growing market for pipette calibration services, driven by expanding pharmaceutical and biotechnology research, increasing laboratory testing activities, growing investments in life sciences, and strengthening quality-management practices across the region. Countries such as China, Japan, India, South Korea, and Australia are developing advanced pharmaceutical, biopharmaceutical, diagnostics, and research ecosystems, increasing the use of precision liquid-handling equipment across research and testing laboratories. In China, national R&D expenditure increased 8.9% in 2024, while expenditure on basic research increased 10.7%, indicating continued expansion of the country's scientific research ecosystem. Japan had approximately 912,800 researchers in 2025, the highest level recorded in the country's latest R&D survey, while total R&D expenditure increased 7.9%, highlighting the country's strong research infrastructure. Australia also recorded substantial research activity, with higher-education R&D expenditure in biomedical and clinical sciences reaching USD 2.41 billion in 2024, while biological sciences accounted for a further AUD 1.37 billion. India continues to strengthen its science and technology ecosystem through government-supported research programs and expansion of R&D infrastructure, while South Korea's growing biotechnology and biopharmaceutical capabilities are supporting increasing laboratory capacity. These developments are expanding the use of pipettes in drug discovery, molecular biology, genomics, diagnostics, quality control, and biopharmaceutical research, thereby increasing the need for accurate and traceable calibration. Furthermore, greater adoption of laboratory accreditation, standardized quality systems, automated liquid handling, and preventive equipment maintenance is encouraging laboratories to use professional calibration providers. Consequently, continued expansion of research and laboratory infrastructure across Asia Pacific is expected to create significant opportunities for pipette calibration services, particularly for on-site calibration, certification, preventive maintenance, and integrated equipment servicing.

Key Market Players

The key players functioning in the pipette calibration services market include Eppendorf SE (Germany), Sartorius AG (Germany), METTLER TOLEDO (US), Thermo Fisher Scientific Inc. (US), Transcat, Inc. (US), and Trescal SAS (France), among others.

Don’t miss out on business opportunities in pipette calibration services. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com